References:

1. Craft JE, Grodzicki RL, Steere AC, Antibody response in Lyme disease: evaluation of tests. J Infect Dis 1984;149:789-95.

2. Magnarelli LA, Meegan JM, Anderson JF, Chappell WA. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Micro 1984;20:181-4.

3. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Micro 1995;33: 419-427.

4. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J Clin Micro 1993;31:3090-95.

5. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Micro 1996;34:1-9.

6. Craft JE, Fischer DK, Shimamoto GT, Steere AC, Antigens of Borrelia burgdorferi recognized during Lyme disease: appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest;78:934-9.

7. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J. Infect Dis. 1993;167:392-400.

8. Association of State and Territorial Public Health Laboratory Directors (ASTPHLD). Proceedings of the second national conference on the serological diagnosis of Lyme disease, October 27-29, 1994. Dearborn MI. Washington DC. ASTPHLD 1995.

9. CDC. Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease: MMWR 1995;44:590-591.

10. Ma B, Christen B, Leung D, Vigo-Pelfry C. Serodiagnosis of Lyme Borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Micro 1992;30:370-76.

11. Hilton E, Devoti J, Sood S. Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease. J Clin Micro 1996;34:1353-54.

12. Jain VK, Hilton E, Maytal J, Dorante G, Ilowite NT, Sood SK. Immunoglobulin M immunoblot for diagnosis of Borrelia burgdorferi infection in patients with acute facial palsy. J Clin Micro 1996;34:2033-35.

12. Golightly MG, Thomas JA, Viciana AL. The laboratory diagnosis of Lyme Borreliosis. Lab Med 1990;21:299-304.

13. Luger SW, Krauss E. Serologic tests for Lyme disease: interlaboratory variability. Arch Intern Med 1990;15:761-3.

14. Mitchell PD, Reed KD, Aspeslet TL Vandermause MF, Melski JW. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Micro 1994;32:1958-62.

15. Magnarelli LA, Anderson JF, Johnson RC. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis 1987;156:183-88.

16. Harris NS, Harris SJ, Joseph JJ, Stephens BG. Borrelia burgdorferi antigen levels in urine and other fluids during the course of treatment for Lyme disease: A case study. Presented at the VII International Congress of Lyme Borreliosis meeting, June 16-21, 1996. San Francisco, CA.

17. Oski J, Uksila J, Marjamaki M, Mikoskelainen J, Viljanen MK. Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41 kilodalton flagellin and P39 protein in patients with PCR- or culture-proven late Lyme Borreliosis. J Clin Micro 1995;33:2260-64.

18. Hyde FW, Johnson RC, White TJ, Shelburne CE. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiolo 1989;27:58-61.

19. Shelburne CE. Method and composition for the diagnosis of Lyme disease. US Patent 4,888,276.1989.

20. Harris NS, Stephens BG. Detection of B. burgdorferi antigen in urine from patients with Lyme Borreliosis. J Spirochet Tick-Borne Dis 1995;2:37-41.

21. Harris N, Drulle J, Eiras E, Stephens B. Detection of B. burgdorferi antigen and antibody in patients presenting with an erythema migrans. Presented at 6th annual Lyme disease scientific conference, May 5-6, 1993. Atlantic City, NJ.

22. Coyle PK, Deng Z, Schutzer SE, et al. Detection of antigens in cerebrospinal fluid. Neurol 1993;43:1093-97.

23. Dorward DW, Schwan TG, Garon CF. Immune capture and detection of extracellular B. burgdorferi antigens in fluids or tissues of ticks, mice, dogs, and humans. J Clin Micro 1991;29:1162-71.

24. Goodman JL, Jurkovich P, Kramber JM, Johnson RC. Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun 1991;59:3-12.

25. Rosa PA, Schwan TG. A specific and sensitive assay for the Lyme disease spirochete B. burgdorferi using the polymerase chain reaction. J Infect Dis 1989;160:1018-29.

26. Persing DH, Telford SR, Spielman A, Barthold SW. Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol 1990;28:566-72.

27. Nocton JJ, Dressler F, Rutledge BJ, Tys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-234.

28. Wilske B, Schierz G, Preac-Mursic V, et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis. J Infect Dis. 1986;153:304-314.

29. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990;161:1203-1209.

30. Coyle PK, Neurologic complications of Lyme disease. Rheum Dis Clin North Am 1993;19:993-1009.

31. Keller TL, Halperin JJ, Whitman M. PCR Detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992;42:32-42.

32. Schmidt B. Muellegger RR, Stochenhuber C, et al. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol 1996;34:1359-63.

33. Benach JL, Coleman JL, Habicht GS. Serologic evidence for simultaneous occurrences of Lyme disease and babesiosis. J Ifect Dis. 1981;144:473-477.

34. Grunwaldt E, Barbour AG, Benach JL. Simultaneous occurrence of babesiosis and Lyme disease. N Engl J Med 1983;308:1166.

35. Anderson JF, Mintz ED, Gadbaw JJ, Magnarelli LA. Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut. J Clin Microbiol 1991;29:2779-83.

36. Magmarelli LA, Dumler SJ, Anderson JF, Johnson RC, Fikrig E. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 1995;33:3054-57.

37. Krause PJ, Telford SR, Spielman A, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA 1996;275:1657-60.

38. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996;34:724-727.

39. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991;29:2838-42.

40. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-15.

41. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994;120:736-43.

42. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.

43. Persing DH, Mathiesen D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992;30:2097-103.

44. Wang, H, et al. Primers are decisive for sensitivity of PCR. Bio Techniques 1994; 17:82-88.

45. Bayer, et al. Borrelia burgdorferi in the urine of treated patients with chronic Lyme disease symptoms. A PCR Study of 97 cases. Infection 1996;24(5):347-53.

IGeneX, Inc.
795 San Antonio Rd., Palo Alto, CA 94303 USA
Tel. 650.424.1191 / 800.832.3200 Fax. 650.424.1196